Clinical Trial Update: Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester

View source ↗

Summary

A completed clinical trial evaluating whether early ultrasound and maternal biochemical markers can assess the risk of Down syndrome in the first trimester.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Down Syndrome | Status: COMPLETED